Cencora, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Cencora, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $321.33B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $293.96B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $262.17B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $238.59B | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | $213.99B | Nov 21, 2023 |
| FY2020 | Sep 30, 2020 | $49.24B | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | $45.37B | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | $47.42B | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | $47.86B | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | $45.64B | Nov 19, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $11.48B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $9.91B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $8.96B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $8.30B | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | $6.94B | Nov 21, 2023 |
| FY2020 | Sep 30, 2020 | $1.35B | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | $1.23B | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | $1.39B | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | $1.23B | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | $1.18B | Nov 19, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.55B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $1.51B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $1.75B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $1.70B | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | $1.54B | Nov 21, 2023 |
| FY2020 | Sep 30, 2020 | ($4.85B) | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | $289.44M | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | $960.28M | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | $187.64M | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | $132.62M | Nov 19, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $2.63B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $2.18B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $2.34B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $2.37B | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | $2.35B | Nov 21, 2023 |
| FY2020 | Sep 30, 2020 | ($6.11B) | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | $404.83M | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | $309.52M | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | $263.44M | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | $179.84M | Nov 19, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $6.49B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $5.66B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $5.31B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $4.85B | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | $3.59B | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $2.77B | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $2.66B | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $2.46B | Nov 19, 2020 |
| FY2019 | Sep 30, 2017 | $2.13B | Nov 19, 2019 |
| FY2018 | Sep 30, 2016 | $2.09B | Nov 20, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.88B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $3.48B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $3.91B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $2.70B | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | $2.67B | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $2.21B | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $2.34B | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $1.41B | Nov 19, 2020 |
| FY2019 | Sep 30, 2017 | $1.50B | Nov 19, 2019 |
| FY2018 | Sep 30, 2016 | $3.18B | Nov 20, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $667.98M | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $487.17M | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $458.36M | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $496.32M | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | $438.22M | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $369.68M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $310.22M | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $336.41M | Nov 19, 2020 |
| FY2019 | Sep 30, 2017 | $466.40M | Nov 19, 2019 |
| FY2018 | Sep 30, 2016 | $464.62M | Nov 20, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $76.59B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $67.10B | Nov 25, 2025 |
| FY2024 | Sep 30, 2023 | $62.56B | Nov 26, 2024 |
| FY2023 | Sep 30, 2022 | $56.56B | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $57.34B | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $44.27B | Nov 23, 2021 |
| FY2020 | Sep 30, 2019 | $39.17B | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $37.67B | Nov 19, 2019 |
| FY2019 | Sep 30, 2017 | $35.32B | Nov 19, 2019 |
| FY2018 | Sep 30, 2016 | $33.64B | Nov 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.51B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $645.94M | Nov 25, 2025 |
| FY2024 | Sep 30, 2023 | $522.00M | Nov 26, 2024 |
| FY2023 | Sep 30, 2022 | ($211.56M) | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $223.35M | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | ($1.02B) | Nov 23, 2021 |
| FY2020 | Sep 30, 2019 | $2.88B | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $2.93B | Nov 19, 2019 |
| FY2018 | Sep 30, 2017 | $2.06B | Nov 20, 2018 |
| FY2017 | Sep 30, 2016 | $2.13B | Nov 21, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $13.68B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $9.32B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $9.57B | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $8.50B | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | $9.03B | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $6.71B | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $6.71B | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $6.66B | Nov 19, 2020 |
| FY2019 | Sep 30, 2017 | $6.04B | Nov 19, 2019 |
| FY2018 | Sep 30, 2016 | $5.99B | Nov 20, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $6.53B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $5.42B | Nov 25, 2025 |
| FY2024 | Sep 30, 2023 | $4.32B | Nov 26, 2024 |
| FY2023 | Sep 30, 2022 | $2.98B | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $1.67B | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $518.34M | Nov 23, 2021 |
| FY2020 | Sep 30, 2019 | $4.24B | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $3.72B | Nov 19, 2019 |
| FY2018 | Sep 30, 2017 | $2.40B | Nov 20, 2018 |
| FY2017 | Sep 30, 2016 | $2.30B | Nov 21, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $4.36B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $3.13B | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $2.59B | Nov 25, 2025 |
| FY2025 | Sep 30, 2022 | $3.39B | Nov 25, 2025 |
| FY2024 | Sep 30, 2021 | $2.55B | Nov 26, 2024 |
| FY2022 | Sep 30, 2020 | $4.60B | Nov 22, 2022 |
| FY2020 | Sep 30, 2019 | $3.37B | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $2.49B | Nov 19, 2019 |
| FY2019 | Sep 30, 2017 | $2.44B | Nov 19, 2019 |
| FY2019 | Sep 30, 2016 | $2.74B | Nov 19, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $7.66B | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $4.39B | Nov 25, 2025 |
| FY2024 | Sep 30, 2023 | $4.79B | Nov 26, 2024 |
| FY2023 | Sep 30, 2022 | $5.70B | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $6.68B | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $4.12B | Nov 23, 2021 |
| FY2020 | Oct 31, 2018 | $400.00M | Nov 19, 2020 |
| FY2017 | Sep 30, 2017 | $3.44B | Nov 21, 2017 |
| FY2017 | Sep 30, 2016 | $4.19B | Nov 21, 2017 |
| FY2016 | Sep 30, 2015 | $3.49B | Nov 22, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 8 | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | 7 | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | 8 | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | 8 | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | 7 | Nov 21, 2023 |
| FY2020 | Sep 30, 2020 | (23) | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | 1 | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | 4 | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Nov 19, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 7 | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | 7 | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | 8 | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | 8 | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | 7 | Nov 21, 2023 |
| FY2020 | Sep 30, 2020 | (23) | Nov 19, 2020 |
| FY2020 | Jun 30, 2020 | 1 | Nov 19, 2020 |
| FY2020 | Mar 31, 2020 | 4 | Nov 19, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Nov 19, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Nov 19, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 193.94M | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | 194.94M | Nov 25, 2025 |
| FY2024 | Sep 30, 2023 | 200.81M | Nov 26, 2024 |
| FY2023 | Sep 30, 2022 | 206.20M | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | 208.09M | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | 204.23M | Nov 23, 2021 |
| FY2020 | Sep 30, 2019 | 206.76M | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | 213.22M | Nov 19, 2019 |
| FY2018 | Sep 30, 2017 | 217.99M | Nov 20, 2018 |
| FY2017 | Sep 30, 2016 | 220.05M | Nov 21, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $437.08M | Nov 25, 2025 |
| FY2025 | Sep 30, 2024 | $416.17M | Nov 25, 2025 |
| FY2025 | Sep 30, 2023 | $398.75M | Nov 25, 2025 |
| FY2024 | Sep 30, 2022 | $391.69M | Nov 26, 2024 |
| FY2023 | Sep 30, 2021 | $366.65M | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $343.58M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $338.97M | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $333.04M | Nov 19, 2020 |
| FY2019 | Sep 30, 2017 | $320.27M | Nov 19, 2019 |
| FY2018 | Sep 30, 2016 | $288.48M | Nov 20, 2018 |